Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation

Diabetes

Volumn 48, Issue 10, 1999, Pages 2066-2073

  Singh, Rekha ^a   Alavi, Nahid ^b   Singh, Ashok K ^c   Leehey, David J ^a,d,e  

^a HINES VA HOSPITAL   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c Hektoen Institute for Medical Research   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e Hines VA Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGENASE; GELATINASE A; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUCOSE; LOSARTAN; PEROXIDASE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; MESANGIUM CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; ZYMOGRAPHY;

ANGIOTENSIN II; ANIMALS; COLLAGENASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; GLOMERULAR MESANGIUM; GLUCOSE; LOSARTAN; MOLECULAR WEIGHT; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032835393     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.10.2066     Document Type: Article

References (39)

1. Adler S: Structure-function relationships associated with extracellular matrix alteration in diabetic glomerulopathy. J Am Soc Nephrol 5:1165-1172, 1994
2. Kreisberg JI, Ayo SH: The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113, 1993
3. McLennan SV, Fisher EJ, Yue DK, Turtle JR: High glucose concentration causes a decrease in mesangium degradation: a factor in the pathogenesis of diabetic nephropathy. Diabetes 43:1041-1045, 1994
4. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media Diabetes 44:929-935, 1995
5. Pugliese G, Pricci F, Mene P, Romeo G, Nofroni I, Giannini S, Cresci B, Galli G, Rotella CM, DiMario U, Pugliese F: High glucose level unmasks a genetic predisposition to enhanced extracellular matrix production in mesangial cells from the Milan normotensive strain. J Am Soc Nephrol 8:406-414, 1997
6. Lewis EJ, Hunsicker LG, Bain RP, Ronde RD, Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
7. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 118: 577-581, 1993
8. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Betani T, Remuzzi G: Short and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 4:40-49, 1993
9. Kohzuki M, Yasujima M, Kanazawa M, Yoshida K, Fu LP, Obara K, Saito T, Abe K: Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats. J Hypertens 13:97-103, 1995
10. Nakamura T, Takahasi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 5:1492-1497, 1995
11. Wolf G, Haberstroh U, Nielson EG: Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107, 1992
12. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulated extracellular matrix protein synthesis through induction of transforming growth factor-γ expression in rat glomerular cells. J Clin Invest 93:2431-2437, 1994
13. Ray PE, Bruggeman LA, Horikoshi A, Aguilera G, Klotman PE: Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin biosynthesis by binding to ATI receptors. Kidney Int 45:177-184, 1994
14. Wolf G, Ziyadeh FN: The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms. Am J Kidney Dis 29:153-163, 1997
15. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536-542, 1994
16. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
17. Wick G, Glanville RW, Timpl R: Characterization of antibodies to basement membrane (type IV) in immunohistological studies, Immunobiology 156: 372-381, 1979
18. Wilson CB: Renal response to immunological glomerular injury. In The Kidney. 5th ed. Brenner BM, Ed. Philadelphia, WB Saunders, 1996, p. 1253-1391
19. Birkedal-Hansen H: Role of matrix metalloproteinases in human peridontal diseases. J Periodontal 64:474-484, 1993
20. Baricos WH, Cortez SL, El-Dahr SS, Schnaper HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
21. Davies M, Thomas G, Martin J, Lovett DH: The purification and characterization of a glomerular basement membrane-degrading proteinase from rat mesangial cell. Biochem J 251:419-425, 1988
22. Martin J, Davies M, Thomas G, Lovett DH: Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 36: 790-801, 1989
23. Reckelhoff JF, Tygart VL, Mitias M, Walcott JL: STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloprotease in rats. Diabetes 42:1425-1432, 1993
24. Schaefer L, Schaefer RM, Ling H, Teschner M, Heidland A: Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 37:567-571, 1994
25. Song RH, Singh AK, Leehey DJ: Decreased proteinase activity in the streptozotocin diabetic rat. Am J Nephrol 19:441-446, 1999
26. Caenazzo C, Garbisa S, Onisto M, Zampieri M, Baggio B, Gambaro G: Effect of glucose and heparin on mesangial 1 (IV) COLL and MMP-2/TIMP-2 mRNA expression. Nephrol Dial Transplant 12:443-448, 1997
27. Del Prete D, Anglani F, Forino M, Ceol M, Fioretto P, Nosadini R, Baggio B, Gambaro G: Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia, 40:1449-1454, 1997
28. Becker BN, Yasuda T, Kondo S, Vaikunth S, Homma T, Harris RC: Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 6:57-66, 1998
29. Wang TT, Wu XH, Zhang SL, Chan JS: Effect of glucose on the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 53:312-319, 1998
30. Ballerman BJ, Skorecki KL, Brenner BM: Reduced glomerular angiotensin II receptor density in early untreated diabetes mellitus in the rat. Am J Physiol 247:F110-F116, 1984
31. Hseuh WA, Anderson PW: Systemic hypertension and the renin-angiotensin system in diabetic vascular complications. Am J Cardiol 72:14H-21H, 1993
32. Cheng HF, Bums KV, Harris RC: Reduced proximal tubule angiotensin II receptor expression in streptozotocin-induced diabetes mellitus. Kidney Int 46:1603-1610, 1994
33. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 54:343-352, 1998
34. Brees DK, Narita I, Ketteler M, Noble NA, Border WA: Effect of high glucose on the expression of plasminogen activator inhibitor (PAI)-1 in rat mesangial cells. J Am Soc Nephrol 4:647, 1993
35. Kagami S, Kuhara T, Okada K, Kuroda Y, Border WA, Noble NA: Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int 51:664-671, 1997
36. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, Border WA: Diabetic kidney disease is linked to elevated expression of transforming growth factor-beta. Proc Natl Acad Sci U S A 90:1814-1818, 1993
37. Hutchison FN, Cui X, Paul RV, Olivero M, Coffman TM: Increase in renal transforming growth factor ßin diabetes is angiotensin II dependent. J Am Soc Nephrol 7:1872-1873, 1996
38. Song RH, Singh AK, Alavi N, Leehey DJ: Decreased collagenase activity of mesangial cells incubated in high glucose media is reversed by neutralizing antibody to transforming growth factor-beta (Abstract). J Am Soc Nephrol 4:972, 1994
39. Leehey DJ, Alavi N, Singh R, Singh AK: Effects of angiotensin (All) and transforming growth factor-beta (TGF-β) on mesangial collagenase activity (Abstract). J Am Soc Nephrol 8:1867, 1997